Laue, Kathrin
Pozzi, Sabina
Zerbib, Johanna
Bertolio, Rebecca
Eliezer, Yonatan
Cohen-Sharir, Yael
Winkler, Tom https://orcid.org/0000-0003-0333-9328
Caputo, Manuel
Ricci, Alessia A. https://orcid.org/0000-0002-3989-0501
Adler, Lital
Khoury, Rami
Longobardi, Giuseppe https://orcid.org/0000-0003-4617-5546
Slutsky, Rachel
Leikin-Frenkel, Alicia I.
Ovadia, Shai https://orcid.org/0000-0002-0307-7631
Lange, Katharina https://orcid.org/0009-0000-7632-8051
Rustighi, Alessandra
Piazza, Silvano
Sacconi, Andrea
Magesh, Rayna Y.
Keller, Faith N.
Berthelet, Jean https://orcid.org/0000-0003-2562-0575
Schäffer, Alexander
Saad, Ron
Israeli Dangoor, Sahar https://orcid.org/0000-0001-8768-4350
Szczepanowska, Karolina https://orcid.org/0000-0003-4689-2350
Barshack, Iris
Liao, Yang
Malitsky, Sergey https://orcid.org/0000-0003-4619-7219
Brandis, Alexander
Broggini, Thomas https://orcid.org/0000-0002-3733-486X
Czabanka, Marcus
Shi, Wei
Merino, Delphine https://orcid.org/0000-0002-8075-6275
Watson, Emma V.
Blandino, Giovanni
Erez, Ayelet https://orcid.org/0000-0002-9696-0393
Ashery-Padan, Ruth
Medyouf, Hind https://orcid.org/0000-0003-4652-9455
Bertero, Luca https://orcid.org/0000-0001-9887-7668
Del Sal, Giannino
Satchi-Fainaro, Ronit https://orcid.org/0000-0002-7360-7837
Ben-David, Uri https://orcid.org/0000-0001-7098-2378
Article History
Received: 7 February 2024
Accepted: 6 November 2025
First Online: 29 December 2025
Competing interests
: R.S.-F. is a board director at Teva Pharmaceutical Industries Ltd. and receives unrelated research funding from Merck KGaA. U.B.-D. received consulting fees from Accent Therapeutics and received unrelated research funding from Novocure. The remaining authors declare no competing interests.